TherapeuticsMD, Inc. (TXMD) Net margin 2016–2025
TherapeuticsMD, Inc. (TXMD) net profit margin by fiscal year — reported net income divided by reported revenue.
-18.8%FY2025 · since FY2016: -464.3% → -18.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -18.8% | +105.0 pp |
| FY2024 | -123.9% | +665.6 pp |
| FY2023 | -789.4% | -949.5 pp |
| FY2022 | 160.1% | +6861.0 pp |
| FY2021 | -6700.9% | -6418.0 pp |
| FY2020 | -282.9% | +71.9 pp |
| FY2019 | -354.8% | +468.9 pp |
| FY2018 | -823.7% | -365.2 pp |
| FY2017 | -458.5% | +5.8 pp |
| FY2016 | -464.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More TXMD financial trends
TXMD RevenueTXMD Net incomeTXMD Gross profitTXMD Gross marginTXMD Operating incomeTXMD Operating marginTXMD Operating cash flowTXMD Free cash flowTXMD Capital expendituresTXMD Return on equityTXMD Stock buybacksTXMD Dividends paidTXMD Total assetsTXMD Total liabilitiesTXMD Shareholders’ equityTXMD overview →